Alavi K - Search Results

1

Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial: Are We Overestimating the Quality of Our Resections?

Sylla P, Berho M, Sands D, Ricardo A, Bonaccorso A, Moshier E, Hain E, Letchinger R, Marks J, Whiteford M, Mclemore E, Maykel J, Alavi K, Zaghiyan K, Chadi S, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Polydorides A, Wexner S. Sylla P, et al. Among authors: alavi k. Ann Surg. 2023 Sep 1;278(3):452-463. doi: 10.1097/SLA.0000000000005948. Epub 2023 Jul 17. Ann Surg. 2023. PMID: 37450694 Clinical Trial.

2

Fistula-associated anal adenocarcinoma: good results with aggressive therapy.

Gaertner WB, Hagerman GF, Finne CO, Alavi K, Jessurun J, Rothenberger DA, Madoff RD. Gaertner WB, et al. Among authors: alavi k. Dis Colon Rectum. 2008 Jul;51(7):1061-7. doi: 10.1007/s10350-008-9294-4. Epub 2008 Apr 17. Dis Colon Rectum. 2008. PMID: 18418652

3

Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome.

Alavi K, Kato Y, Yu D, Schwartz MZ. Alavi K, et al. J Pediatr Surg. 1998 Nov;33(11):1666-9. doi: 10.1016/s0022-3468(98)90605-4. J Pediatr Surg. 1998. PMID: 9856891

4

Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation.

Alavi K, Prasad R, Lundgren K, Schwartz MZ. Alavi K, et al. J Pediatr Surg. 2000 Feb;35(2):371-4. doi: 10.1016/s0022-3468(00)90043-5. J Pediatr Surg. 2000. PMID: 10693699

5

Career options in colon and rectal surgery.

Alavi K, Madoff RD, Rothenberger DA. Alavi K, et al. Clin Colon Rectal Surg. 2011 Jun;24(2):89-93. doi: 10.1055/s-0031-1278403. Clin Colon Rectal Surg. 2011. PMID: 22654567 Free PMC article.

6

Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion.

Prasad R, Alavi K, Schwartz MZ. Prasad R, et al. Among authors: alavi k. J Pediatr Surg. 2000 Feb;35(2):357-9. doi: 10.1016/s0022-3468(00)90040-x. J Pediatr Surg. 2000. PMID: 10693696

7

Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury.

Rajeevprasad R, Alavi K, Schwartz MZ. Rajeevprasad R, et al. Among authors: alavi k. J Pediatr Surg. 2000 Nov;35(11):1537-9. doi: 10.1053/jpsu.2000.18301. J Pediatr Surg. 2000. PMID: 11083417

8

Leptin: a new growth factor for the small intestine.

Alavi K, Schwartz MZ, Prasad R, O'connor D, Funanage V. Alavi K, et al. J Pediatr Surg. 2002 Mar;37(3):327-30. doi: 10.1053/jpsu.2002.30805. J Pediatr Surg. 2002. PMID: 11877642

9

Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.

Alavi K, Schwartz MZ, Palazzo JP, Prasad R. Alavi K, et al. J Pediatr Surg. 2000 Jun;35(6):847-51. doi: 10.1053/jpsu.2000.6861. J Pediatr Surg. 2000. PMID: 10873024

10

GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.

Prasad R, Alavi K, Schwartz MZ. Prasad R, et al. Among authors: alavi k. J Pediatr Surg. 2001 Apr;36(4):570-2. doi: 10.1053/jpsu.2001.22284. J Pediatr Surg. 2001. PMID: 11283879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters